Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Abbott Laboratories (ABT)

3K + Investors. Track Smart Money conviction in ABT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -152
Streak
1Q ▼
Buyers last Q
43%

Smart Money Signals — ABT

Based on 3090 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their ABT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (95% of max)

95% of all-time peak
3,090 hedge funds hold ABT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding ABT is almost the same as a year ago (-13 funds, 0% change). No significant rush to buy or sell — institutional backing is holding steady.
🟠

More sellers than buyers — 43% buying

1325 buying1785 selling
Last quarter: 1,785 funds reduced or exited vs 1,325 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-139 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 200 → 190 → 349 → 210. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

75% of holders stayed for 2+ years

■ 75% conviction (2yr+) ■ 14% medium ■ 12% new
2,313 out of 3,090 hedge funds have held ABT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -5%, value -22%

Value
-21%
Shares
-5%
Last quarter: funds added -5% more shares while total portfolio value only changed -22%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

301 → 200 → 190 → 349 → 210 new funds/Q
New funds entering each quarter: 200 → 190 → 349 → 210. A growing number of institutions are discovering ABT each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 76% veterans vs 14% newcomers

■ 76% veterans ■ 10% 1-2yr ■ 14% new
Entry-cohort mix of 3,165 holders: 2,397 (76%) are 2+ year veterans, 318 entered 1–2 years ago, and 450 (14%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 51% AUM from top-100 funds

51% from top-100 AUM funds
71 of 3080 holders are among the 100 largest funds by AUM, controlling 51% of total institutional value in ABT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ABT

In 2026 Q1, 1325 hedge funds were net buyers of ABT (210 opened a new position, 1115 added to an existing one), while 1785 reduced or exited (1423 trimmed, 362 sold completely) — a 43% buyer ratio, indicating roughly balanced activity. 51% of total institutional value in ABT is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -152 funds (more exits than new entries). Total institutional holders: 3090.

Hedge Fund Ownership: ABT

How many hedge funds hold ABT — quarterly history vs. share price
Quarterly hedge fund ownership of ABT vs. share price

Market Analysis: ABT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ABT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Abbott Laboratories (ABT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ABT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 78d ago
ABT
-13.0%
XLV
+3.6%

ABT outperformed XLV by -16.6% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 33d ago
ABT
+5.8%
XLV
+4.6%

Since the filing became public, ABT outperformed XLV by +1.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

134 top-rated funds 23 high-conviction
Consensus
9.2
/ 10
breadth
×
Elite
4.0
/ 10
conviction
Hedge Fund Positioning: ABT
3K + Investors

Track Smart Money conviction in ABT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 3046 3242 -6.05%
13F Shares 1.36B 1.44B -5.5%
Total Value $135.07B $172.69B -21.78%
New Positions 201 349 -148
Increased Positions 1096 1126 -30
Closed Positions 397 233 +164
Reduced Positions 1382 1339 +43
Total Calls 42 35 20.0%
Total Puts 41 38 7.89%
PUT/CALL Ratio 0.98 1.09 Neutral

Statistics: ABT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

3K + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ABT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ABT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Cura Wealth Advisors, LLC 10.55% 229,627 $23.6M
2 Patrick M Sweeney & Associates, Inc 4.89% 74,291 $7.6M
3 Coerente Capital Management 4.32% 226,208 $23.2M
4 Letson Investment Management, INC. 4.29% 108,705 $11.2M
5 America First Investment Advisors, LLC 4.24% 221,538 $22.7M
6 Sugar Maple Asset Management, LLC 4.18% 67,002 $6.9M
7 Absher Wealth Management, LLC 4.01% 333,127 $34.2M
8 WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 3.96% 3,125,000 $320.8M
9 Flossbach von Storch Se 3.76% 7,858,443 $806.8M
10 Rbo & Co LLC 3.61% 217,815 $22.4M
11 Dundas Partners LLP 3.47% 423,933 $43.5M
12 Diamond Hill Capital Management Inc 3.45% 5,378,840 $552.2M
13 Evolutionary Tree Capital Management, LLC 3.45% 17,867 $1.8M
14 Bruce & Co., Inc. 3.34% 113,800 $11.7M
15 Woodley Farra Manion Portfolio Management Inc 3.22% 643,571 $66.1M
16 First Long Island Investors, LLC 3.18% 381,973 $39.2M
17 Tandem Investment Advisors, Inc. 3.17% 630,596 $64.7M
18 J. Stern & Co. LLP 3.14% 315,958 $32.4M
19 Elefante Mark B 3.05% 54,056 $5.5M
20 Delaney Dennis R 3.04% 83,748 $8.6M
21 Jensen Investment Management Inc 3.01% 1,486,036 $152.6M
22 Swisher Financial Concepts, Inc. 2.95% 51,431 $5.3M
23 Borer Denton & Associates, Inc. 2.89% 78,811 $8.1M
24 Mv Capital Management, INC. 2.85% 282,498 $29.0M
25 Locust Wood Capital Advisers, LLC 2.82% 1,077,201 $110.6M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Abbott Laboratories (ABT)

What does the Smart Money Trend signal show for ABT?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their ABT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for ABT?

More sellers than buyers — 43% buying: Last quarter: 1,785 funds reduced or exited vs 1,325 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for ABT holders?

Elite ownership — 51% AUM from top-100 funds: 71 of 3080 holders are among the 100 largest funds by AUM, controlling 51% of total institutional value in ABT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ABT?

75% of holders stayed for 2+ years: 2,313 out of 3,090 hedge funds have held ABT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Abbott Laboratories (ABT) following the 2026 Q1 hedge fund 13F filings?

As of today, ABT has moved +5.8% since the 2026 Q1 13F filing date (May 15, 2026), compared to +4.6% for the XLV sector ETF — an outperformance of +1.2%. Since the quarter end (March 31, 2026), ABT has gained -13.0% vs +3.6% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →